Abstract
Genetic alterations in BRAF, RAS or RET genes are associated to thyroid cancer oncogenesis, being BRAFT1799A (BRAFV600E) mutation the most frequent and associated with greater aggressiveness and poor prognosis. Aggressive thyroid carcinomas show loss of cell differentiation and improved capacity of invasion and migration, due to the activation of epithelial-mesenchymal transition process.…